Pleural mesothelioma is a rare and aggressive cancer. The cancer with a poor prognosis is mainly caused by asbestos. Surgery is an important part of treating pleural mesothelioma, but the impact of surgery on patients’ survival is unclear and sparking debate. A recent study was presented at the World Conference[…]
Novel Treatments & Drugs
Opdivo and Yervoy Before and After Surgery and a New Blood Test are Improving Mesothelioma Treatment
Researchers are reporting promising results for people with mesothelioma who can have surgery. One researcher tested immunotherapy before and after surgery while the other researcher studied a blood test that helps doctors detect mesothelioma earlier than scans. Doctors at several cancer centers, including Johns Hopkins, ran an early clinical trial[…]
MARS 2 Trial for Mesothelioma
Pleural mesothelioma is a rare and aggressive cancer that is linked to asbestos exposure. It affects the lining of the lungs. Every year, there are over 2,500 people in the United Kingdom that are diagnosed with the cancer. A study known as MARS 2 investigated if adding surgery to chemotherapy[…]
Immunotherapy Might Not Be a Good Option for Mesothelioma
Mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure that creates challenges for patients and caregivers. Immune checkpoint inhibitors have brought hope to patients, but new data from Australia is raising questions about their safety and effectiveness. In order to make informed decisions, patients must understand all[…]
CRS and HIPEC for Peritoneal Mesothelioma
Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article explains cytoreductive surgery and HIPEC for the treatment of peritoneal mesothelioma. Cytoreductive surgery removes as many tumors as possible. In[…]
Immunotherapy to Treat Pleural Mesothelioma
Malignant pleural mesothelioma is a rare and very aggressive cancer with a poor outlook. One cancer treatment has brought hope though. The treatment is known as immune checkpoint inhibitors. There is potential for better outcomes when patients are given this treatment. A new article in Open Respiratory Archives provides a[…]
Drug Factories to Treat Mesothelioma
Researchers from Rice University and Baylor College of Medicine developed a new treatment that can eliminate advanced stage mesothelioma tumors in mice within days. The breakthrough treatment used Rice’s cytokine drug factory implants with a checkpoint inhibitor drug. This combination is showing great potential in mesothelioma preclinical trials. The treatment[…]
Decision Making Tools for Mesothelioma
Mesothelioma, a cancer mainly caused by asbestos exposure, is very rare and aggressive. There are many challenges that doctors face when diagnosing, treating, and managing this cancer. Advances in medical technology and data analytics are helping doctors make crucial decisions for patients struggling with the hard to treat and deadly[…]
Immune Checkpoint Inhibitors for the Treatment of Mesothelioma
Mesothelioma is a rare, aggressive cancer mainly caused by asbestos exposure. One treatment that is giving hope to patients and caregivers is the use of immune checkpoint inhibitors. A new study from Australia has raised questions about the effectiveness and safety of this novel treatment. In order to best care[…]
Using Precision Cut Tumor Slices to Advance Mesothelioma Treatment
Malignant pleural mesothelioma is a cancer mainly caused by asbestos exposure that is very deadly. Research continues to be done on the cancer, giving hope to patients and their families. One tool in the fight against mesothelioma is ex-vivo models using precision cut tumor slices. A new article looks at[…]
